Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 22, Issue 2, 2015, Pages 126-134

  Wang, J Y ^a   Mao, R C ^a   Zhang, Y M ^a   Zhang, Y J ^a   Liu, H Y ^a   Qin, Y L ^a   Lu, M J ^b   Zhang, J M ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Biomarker; chronic HBV infection; diagnosis; liver necroinflammation; microRNA 124

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MICRORNA 124; ANTIVIRUS AGENT; MICRORNA; MIRN124 MICRORNA, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS; DISEASE SEVERITY; FEMALE; HEPATITIS; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER NECROINFLAMMATION; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; AGED; BIOPSY; BLOOD; DIAGNOSTIC TEST; EVALUATION STUDY; HEPATITIS B, CHRONIC; LIVER; MIDDLE AGED; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84921374864     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12284     Document Type: Article

References (30)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV,. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38 (10 Suppl 3): S158-S168.
2. Liang X, Bi S, Yang W, et al,. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27 (47): 6550-6557.
3. Tiollais P, Pourcel C, Dejean A,. The hepatitis B virus. Nature 1985; 317 (6037): 489-495.
4. Lok AS, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45 (2): 507-539.
5. Liver EAFTSOT. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57 (1): 167-185.
6. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH,. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007; 47 (6): 760-767.
7. Chen EQ, Huang FJ, He LL, et al,. Histological changes in Chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci 2010; 55 (2): 432-437.
8. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344 (7): 495-500.
9. Colloredo G, Guido M, Sonzogni A, Leandro G,. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39 (2): 239-244.
10. Maharaj B, Maharaj RJ, Leary WP, et al,. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1 (8480): 523-525.
11. Regev A, Berho M, Jeffers LJ, et al,. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97 (10): 2614-2618.
12. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355.
13. Elfimova N, Schlattjan M, Sowa JP, Dienes HP, Canbay A, Odenthal M,. Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis. Front Physiol 2012; 3: 476.
14. Arataki K, Hayes CN, Akamatsu S, et al,. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virol 2013; 85 (5): 789-798.
15. Ji F, Yang B, Peng X, Ding H, You H, Tien P,. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepatitis 2011; 18 (7): e242-e251.
16. Bala S, Petrasek J, Mundkur S, et al,. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012; 56 (5): 1946-1957.
17. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J,. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31 (5): 766-776.
18. Li KK, Pang JC, Ching AK, et al,. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 2009; 40 (9): 1234-1243.
19. Koukos G, Polytarchou C, Kaplan JL, et al,. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 2013; 145 (4): 842-852. e2.
20. Liver EAFTSOT. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50 (2): 227-242.
21. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ,. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19 (6): 1513-1520.
22. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3 (6): 1101-1108.
23. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B,. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One 2013; 8 (3): e58236.
24. Vardar R, Vardar E, Demiri S, et al,. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 2009; 56 (94-95): 1459-1465.
25. De Franchis R, D'Arminio A, Vecchi M, et al,. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV. Gastroenterology 1980; 79 (3): 521-527.
26. Lesmana CR, Gani RA, Hasan I, et al,. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia. J Dig Dis 2011; 12 (6): 476-480.
27. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50 (3): 661-662.
28. Rizzo L, Calvaruso V, Cacopardo B, et al,. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2011; 106 (12): 2112-2120.
29. Sun Y, Li Q, Gui H, et al,. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res 2013; 23 (11): 1270-1283.
30. Veremeyko T, Siddiqui S, Sotnikov I, Yung A, Ponomarev ED,. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS One 2013; 8 (12): e81774.